在IgE介导的过敏反应中对光学神经omyelitis中的tocilizumab进行有效的脱敏
Francisca Cunha1, Pedro Alves1, João Cardoso Lopes1
1Allergy and Clinical Immunology Department, Coimbra Hospitalar and University Center, Coimbra, Portugal.
Asia Pacific allergy
|March 7, 2025
概括
用于光学神经炎的托西利祖马布可以引起罕见的过敏反应. 一名患者经历了严重反应,但成功进行了脱敏,突出显示了对单克隆抗体治疗的过敏治疗的重要性.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 光学神经炎是一种罕见的自身免疫性中枢神经系统疾病.
- 托西利祖马布抑制了互白素-6受体,这是光学神经炎的一个关键媒介.
- 对包括托西利祖马布在内的生物药物过敏反应并不常见,但有可能发生.
研究的目的:
- 在患有光学神经omyelitis的患者中报告对tocilizumab严重过敏的病例.
- 评估对托西利祖马布诱导过敏的药物脱敏的疗效和安全性.
- 强调过敏治疗在对单克隆抗体过敏的管理中的作用.
主要方法:
- 一个50岁的女性患有光学神经炎的病例介绍.
- 进行托西利祖马布皮肤测试 (皮内测试1/1,000).
- 在皮肤检测结果呈阳性后启动药物脱敏方案.
主要成果:
- 该患者在托西利祖马布皮肤测试中呈阳性结果.
- 患者成功完成了22个无事件的脱敏周期.
- 在脱敏过程中没有报告任何不良事件.
结论:
- 药物脱敏是一种可行的选择,对于患有对托西利祖马布过敏的患者.
- 对过敏反应的表型定型对于最佳的患者管理至关重要.
- 过敏性工作对于在治疗单克隆抗体诱导过敏症患者时做出明智决策至关重要.
更多相关视频
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
01:20Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K